CAS 75620-25-6

1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-5-(phenylmethyl)-

Description:

1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-5-(phenylmethyl)-, identified by CAS number 75620-25-6, is a heterocyclic compound featuring a benzothiazepine core. This compound typically exhibits a fused bicyclic structure that includes a thiazepine ring, which is characterized by the presence of both sulfur and nitrogen atoms within the ring system. The compound is known for its potential pharmacological properties, often investigated for its effects on the central nervous system and as a possible therapeutic agent. Its structure includes a phenylmethyl group, which may influence its biological activity and solubility. The presence of the carbonyl group in the benzothiazepine framework can also contribute to its reactivity and interaction with biological targets. Overall, this compound represents a class of substances that may have diverse applications in medicinal chemistry, particularly in the development of new drugs targeting various health conditions.

Formula: C₁₆H₁₅NOS

InChI: InChI=1S/C16H15NOS/c18-16-10-11-19-15-9-5-4-8-14(15)17(16)12-13-6-2-1-3-7-13/h1-9H,10-12H2

InChI key: SZCPFKAKAAZJDH-UHFFFAOYSA-N

SMILES: C1CSC2=CC=CC=C2N(C1=O)CC3=CC=CC=C3

Synonyms:

• WAY-333175
• 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-5-(phenylmethyl)-

WAY-333175

CAS: 75620-25-6

WAY-333175

Formula: C₁₆H₁₅NOS

Purity: ≥98%

Molecular weight: 269.36

Ref: 54-OR1107806

WAY-333175

CAS: 75620-25-6

Formula: C₁₆H₁₅NOS

Purity: 98%

Molecular weight: 269.3614

Ref: IN-DA02DJVN

GSK-3β inhibitor 25

CAS: 75620-25-6

GSK-3β inhibitor25 (Compound 6h) exhibits weak inhibitory activity against GSK-3β with an IC50 greater than 100 μM.

Formula: C₁₆H₁₅NOS

Color and Shape: Solid

Molecular weight: 269.361

Ref: TM-T204501